Lidocort Cream
NDC Package 59088-430-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidocort (lidocaine hcl - hydrocortisone acetate) cream is product is used for the anti-inflammatory and anesthetic relief of itching, pain, soreness and discomfort due to hemorrhoids, anal fissures, pruritus ani and similar conditions of the anal area. This formulation utilizes a cream delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-430.

Identification & Billing

NDC Package Code
59088-430-05
Package Description
85 g in 1 TUBE
Product Code
59088-430
11-Digit Billing Format
59088043005
RxNorm Crosswalk
  • RxCUI: 1012235 - hydrocortisone acetate 0.5 % / lidocaine HCl 3 % Rectal Cream
  • RxCUI: 1012235 - hydrocortisone acetate 5 MG/ML / lidocaine hydrochloride 30 MG/ML Rectal Cream
  • RxCUI: 1012235 - hydrocortisone acetate 0.5 % / lidocaine hydrochloride 3 % Rectal Cream

Clinical Specifications

Proprietary Name
Lidocort
Non-Proprietary Name
Lidocaine Hcl - Hydrocortisone Acetate
Substance Name
Hydrocortisone Acetate; Lidocaine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
  • Rectal - Administration to the rectum.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Product is used for the anti-inflammatory and anesthetic relief of itching, pain, soreness and discomfort due to hemorrhoids, anal fissures, pruritus ani and similar conditions of the anal area.

Regulatory & Marketing

Labeler Name
Puretek Corporation
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59088-430-05 identifies a specific commercial package of 85 g in 1 tube of Lidocort, a human prescription drug labeled by Puretek Corporation. This cream is formulated for rectal; topical use and contains hydrocortisone acetate; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on September 01, 2020. The current certification is valid through December 31, 2026.

How is this Puretek Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088043005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59088-430-05
11-Digit CMS (5-4-2)
59088-0430-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.